» Articles » PMID: 34753993

Characterising Clinical Staphylococcus Aureus Isolates from the Sinuses of Patients with Chronic Rhinosinusitis

Overview
Journal Sci Rep
Specialty Science
Date 2021 Nov 10
PMID 34753993
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The role of Staphylococcus aureus in the pathogenesis of the chronic sinonasal disease chronic rhinosinusitis (CRS), has not been definitively established. Comparative analyses of S. aureus isolates from CRS with those from control participants may offer insight into a possible pathogenic link between this organism and CRS. The intra- and inter-subject S. aureus strain-level diversity in the sinuses of patients with and without CRS were compared in this cross-sectional study. In total, 100 patients (CRS = 64, control = 36) were screened for S. aureus carriage. The overall carriage prevalence of S. aureus in this cohort was 24% (CRS n = 13, control n = 11). Cultured S. aureus isolates from 18 participants were strain-typed using spa gene sequencing. The bacterial community composition of the middle meatus was assessed using amplicon sequencing targeting the V3V4 hypervariable region of the bacterial 16S rRNA gene. S. aureus isolates cultured from patients were grown in co-culture with the commensal bacterium Dolosigranulum pigrum and characterised. All participants harboured a single S. aureus strain and no trend in disease-specific strain-level diversity was observed. Bacterial community analyses revealed a significant negative correlation in the relative abundances of S. aureus and D. pigrum sequences, suggesting an antagonistic interaction between these organisms. Co-cultivation experiments with these bacteria, however, did not confirm this interaction in vitro. We saw no significant associations of CRS disease with S. aureus strain types. The functional role that S. aureus occupies in CRS likely depends on other factors such as variations in gene expression and interactions with other members of the sinus bacterial community.

Citing Articles

Dolosigranulum pigrum: A promising nasal probiotic candidate.

Stubbendieck R, Hurst J, Kelly M PLoS Pathog. 2024; 20(2):e1011955.

PMID: 38300905 PMC: 10833571. DOI: 10.1371/journal.ppat.1011955.


Polymyxin B and ethylenediaminetetraacetic acid act synergistically against and .

Hale S, Cameron A, Lux C, Biswas K, Kim R, OCarroll M Microbiol Spectr. 2024; 12(2):e0170923.

PMID: 38168683 PMC: 10845947. DOI: 10.1128/spectrum.01709-23.


Fluorescence in situ hybridisation in Carnoy's fixed tonsil tissue.

Clark S, Waldvogel-Thurlow S, Wagner Mackenzie B, Douglas R, Biswas K Sci Rep. 2022; 12(1):12395.

PMID: 35858968 PMC: 9300673. DOI: 10.1038/s41598-022-16309-w.

References
1.
Brugger S, Eslami S, Pettigrew M, F Escapa I, Henke M, Kong Y . Dolosigranulum pigrum Cooperation and Competition in Human Nasal Microbiota. mSphere. 2020; 5(5). PMC: 7485692. DOI: 10.1128/mSphere.00852-20. View

2.
Lux C, Wagner Mackenzie B, Johnston J, Zoing M, Biswas K, Taylor M . Antibiotic Treatment for Chronic Rhinosinusitis: Prescription Patterns and Associations With Patient Outcome and the Sinus Microbiota. Front Microbiol. 2021; 11:595555. PMC: 7782326. DOI: 10.3389/fmicb.2020.595555. View

3.
Jarraud S, Mougel C, Thioulouse J, Lina G, Meugnier H, Forey F . Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun. 2002; 70(2):631-41. PMC: 127674. DOI: 10.1128/IAI.70.2.631-641.2002. View

4.
Thunberg U, Soderquist B, Hugosson S . Bacterial findings in optimised sampling and characterisation of S. aureus in chronic rhinosinusitis. Eur Arch Otorhinolaryngol. 2016; 274(1):311-319. PMC: 5222931. DOI: 10.1007/s00405-016-4239-3. View

5.
Ou J, Wang J, Xu Y, Tao Z, Kong Y, Chen S . Staphylococcus aureus superantigens are associated with chronic rhinosinusitis with nasal polyps: a meta-analysis. Eur Arch Otorhinolaryngol. 2014; 271(10):2729-36. DOI: 10.1007/s00405-014-2955-0. View